For Q3 FY2026 ended December 31, 2025, Prestige Consumer Healthcare reported revenue of $283.4 million, down 2.4% year-over-year. Net income was $46.7 million, a decrease of 23.5%, and operating income fell 10.3% to $82.5 million. Diluted EPS declined 20.5% to $0.97.
•Revenue decreased 2.4% YoY to $283.4 million.
•Net income fell 23.5% to $46.7 million.
•Operating income dropped 10.3% to $82.5 million.
•Diluted EPS was $0.97, down 20.5% from prior year.
Informational summary based on SEC XBRL figures · generated by deepseek-v4-flash. Not investment advice.
Prestige Consumer Healthcare develops, manufactures, markets, distributes, and sells over the counter (OTC) health and personal care products globally. It operates in two segments, North American OTC Healthcare and International OTC Healthcare. The company offers analgesic powders under the BC and Goody's brand.
Its portfolio also includes various diaper rash treatments and skin protectants for babies under the Boudreaux's Butt Paste brand name, sprays and lozenges to relieve sore throats and mouth pain under the Chloraseptic brand, eye care products that provide relief from redness and itchiness under the Clear Eyes brand name, at-home removal of common and plantar warts under the Compound W brand, and ear wax removal products under the Debrox brand name, as well as dental guards, floss picks, interdental brushes, dental repair and kits, and tongue cleaners under the DenTek brand.
Its portfolio also includes motion sickness relief products under the Dramamine brand, enemas and laxative products under the Fleet brand name, stomach upset remedies under the Gaviscon brand, cough drops under the Luden's brand, products for yeast infections in women under the Monistat brand name, lice and parasite treatments under the Nix name, feminine care products
Including washes, cloths, and sprays under the Summer's Eve brand, products for dry eyes under the TheraTears brand, nasal saline sprays and washes under the Fess brand name, and oral rehydration products under the Hydralyte brand.
Products are distributed to mass merchandisers; and drug, food, dollar, convenience, and club stores, as well as e-commerce channels. Founded in 1996 and headquartered in Tarrytown, New York, Prestige Consumer Healthcare was formerly known as Prestige Brands Holdings, Inc. before rebranding in August 2018.
What does Prestige Consumer Healthcare Inc. (PBH) do?
Prestige Consumer Healthcare Inc. develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products globally. The company operates through two segments: North American OTC Healthcare and International OTC Healthcare. Its product portfolio includes well-known brands such as BC and Goody's analgesic powders, Boudreaux's Butt Paste for diaper rash, Chloraseptic sore throat sprays and lozenges, Clear Eyes eye care products, Compound W wart removal, Debrox ear wax removal, DenTek dental care products, Dramamine motion sickness relief, Fleet enemas and laxatives, Gaviscon stomach upset remedies, Luden's cough drops, Monistat yeast infection treatments, Nix lice and parasite treatments, Summer's Eve feminine care, TheraTears dry eye products, Fess nasal saline sprays, and Hydralyte oral rehydration products. These products are distributed to mass merchandisers, drug stores, food stores, dollar stores, convenience stores, and club stores.
Where is Prestige Consumer Healthcare (PBH) listed and in which currency?
Prestige Consumer Healthcare Inc. is listed on the New York Stock Exchange (NYSE) under the ticker symbol PBH. The company's financial reporting and stock trading are conducted in US Dollars (USD). As a US-based company, its shares are traded in the primary US equity market, providing investors with exposure to the consumer healthcare sector.
What sector and industry does Prestige Consumer Healthcare (PBH) belong to?
Prestige Consumer Healthcare Inc. operates in the Healthcare sector, specifically within the Drug Manufacturers - Specialty & Generic industry. This classification indicates that the company is primarily involved in manufacturing and marketing over-the-counter (OTC) medications and personal care products, focusing on specialty and generic drug categories. Unlike prescription drug manufacturers, Prestige's products are available without a prescription and are sold directly to consumers through retail channels.
What are the main product categories of Prestige Consumer Healthcare (PBH)?
Prestige Consumer Healthcare offers a diverse range of OTC health and personal care products across multiple categories. Key product categories include pain relief (BC and Goody's analgesic powders), baby care (Boudreaux's Butt Paste), oral care (Chloraseptic, DenTek dental products), eye care (Clear Eyes, TheraTears), dermatological treatments (Compound W wart removal), ear care (Debrox), digestive health (Dramamine, Fleet, Gaviscon), cough and cold (Luden's cough drops), women's health (Monistat, Summer's Eve), and lice treatment (Nix). Additionally, the company offers nasal care (Fess saline sprays) and oral rehydration solutions (Hydralyte). This broad portfolio allows the company to serve various consumer health needs through well-recognized brands.
How does Prestige Consumer Healthcare (PBH) distribute its products?
Prestige Consumer Healthcare distributes its products through a wide network of retail channels, including mass merchandisers (such as Walmart and Target), drug stores (like CVS and Walgreens), food stores (grocery chains), dollar stores, convenience stores, and club stores (such as Costco and Sam's Club). This multi-channel distribution strategy ensures that the company's OTC health and personal care products are widely accessible to consumers across the United States and internationally. By leveraging relationships with major retailers, Prestige maximizes its market reach and brand visibility.